Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yao-Yu Hsieh

Showing results (11-20 of 48) with videos related to

Pageof 5
Sort By:
Biomolecules|September 12, 2019
In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer CellsJung-Chien Chen, Yao-Yu Hsieh, Hsiang-Ling Lo, et al.
Oncotarget|April 2, 2016
Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabineYao-Yu Hsieh, Tsui-Chin Huang, Hsiang-Ling Lo, et al.
Japanese Journal of Clinical Oncology|September 10, 2010
Sudden-onset pancytopenia with intracranial hemorrhage after oxaliplatin treatment: a case report and literature reviewChung-Jen Teng, Yao-Yu Hsieh, Kuo-Wei Chen, et al.
Genes|October 2, 2019
Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal AdenocarcinomaYao-Yu Hsieh, Tsang-Pai Liu, Chia-Jung Chou, et al.
Oncotarget|September 8, 2018
Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabineYao-Yu Hsieh, Tsui-Chin Huang, Hsiang-Ling Lo, et al.
Cells|April 12, 2024
Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 DetectionChia-Hwa Lee, Kai-Wen Hsu, Yao-Yu Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 10, 2025
Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinomaPei-Jui Luo, Kai-I Chuang, Cheng-Fu Ni, et al.
Journal of the Chinese Medical Association : JCMA|July 7, 2010
Cetuximab-based therapy in recurrent/metastatic head and neck squamous cell carcinoma: experience from an area in which betel nut chewing is popularPeter Mu-Hsin Chang, Yao-Yu Hsieh, Ming-Huang Chen, et al.
American Journal of Cancer Research|January 13, 2025
Continuing anti-EGFR monoclonal antibody after secondary resection significantly prolongs overall survival for patients with metastatic colorectal cancer who were responsive to first-line anti-EGFR monoclonal antibody plus chemotherapy doubletYao-Yu Hsieh, Yu-Li Su, Feng-Che Kuan, et al.
Journal of the Chinese Medical Association : JCMA|November 22, 2011
Pretreatment risk stratification for non-metastatic head and neck squamous cell carcinoma in a high-prevalence areaYao-Yu Hsieh, Peter Mu-Hsin Chang, Ming-Huang Chen, et al.
Pageof 5

Showing results (11-20 of 48) with videos related to

Sort By:
Pageof 5
Biomolecules|September 12, 2019
In Vitro and In Silico Mechanistic Insights into miR-21-5p-Mediated Topoisomerase Drug Resistance in Human Colorectal Cancer CellsJung-Chien Chen, Yao-Yu Hsieh, Hsiang-Ling Lo, et al.
Oncotarget|April 2, 2016
Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabineYao-Yu Hsieh, Tsui-Chin Huang, Hsiang-Ling Lo, et al.
Japanese Journal of Clinical Oncology|September 10, 2010
Sudden-onset pancytopenia with intracranial hemorrhage after oxaliplatin treatment: a case report and literature reviewChung-Jen Teng, Yao-Yu Hsieh, Kuo-Wei Chen, et al.
Genes|October 2, 2019
Integration of Bioinformatics Resources Reveals the Therapeutic Benefits of Gemcitabine and Cell Cycle Intervention in SMAD4-Deleted Pancreatic Ductal AdenocarcinomaYao-Yu Hsieh, Tsang-Pai Liu, Chia-Jung Chou, et al.
Oncotarget|September 8, 2018
Correction: Systematic discovery of drug action mechanisms by an integrated chemical genomics approach: identification of functional disparities between azacytidine and decitabineYao-Yu Hsieh, Tsui-Chin Huang, Hsiang-Ling Lo, et al.
Cells|April 12, 2024
Unveiling IL6R and MYC as Targeting Biomarkers in Imatinib-Resistant Chronic Myeloid Leukemia through Advanced Non-Invasive Apoptosis Detection Sensor Version 2 DetectionChia-Hwa Lee, Kai-Wen Hsu, Yao-Yu Hsieh, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi|January 10, 2025
Sarcopenia and myosteatosis are associated with low survival in patients receiving lenvatinib for unresectable hepatocellular carcinomaPei-Jui Luo, Kai-I Chuang, Cheng-Fu Ni, et al.
Journal of the Chinese Medical Association : JCMA|July 7, 2010
Cetuximab-based therapy in recurrent/metastatic head and neck squamous cell carcinoma: experience from an area in which betel nut chewing is popularPeter Mu-Hsin Chang, Yao-Yu Hsieh, Ming-Huang Chen, et al.
American Journal of Cancer Research|January 13, 2025
Continuing anti-EGFR monoclonal antibody after secondary resection significantly prolongs overall survival for patients with metastatic colorectal cancer who were responsive to first-line anti-EGFR monoclonal antibody plus chemotherapy doubletYao-Yu Hsieh, Yu-Li Su, Feng-Che Kuan, et al.
Journal of the Chinese Medical Association : JCMA|November 22, 2011
Pretreatment risk stratification for non-metastatic head and neck squamous cell carcinoma in a high-prevalence areaYao-Yu Hsieh, Peter Mu-Hsin Chang, Ming-Huang Chen, et al.
Pageof 5